Global impression of change.
Immunoglobulin G. Patient's global impression of change.
Function was assessed by using the FIM™ instrument and a clinical global impression of change.
Data regarding their global impression of change 1-week after treatment were collected.
The patient's overall response to treatment assessed using the Patient Global Impression of Change.
For the evaluation of safety, we used drug-induced extrapyramidal symptoms (DIEPS) questionnaire, and the clinical improvement was assessed with clinical global clinical impression of change (C-GIC) and patients' global clinical impression of change (P-GIC).
The secondary endpoint was the patient's overall response to treatment, assessed using the Patient Global Impression of Change.
Global assessment of the overall response to treatment on the basis of the Patient Global Impression of Change (PGIC) scale.
Efficacy was measured on the Brief Pain Inventory (BPI) and by the clinician global impression of change.
Patients' subjective impression of change is an important construct to measure following physiotherapy, but little evidence exists about the best type of measure to use.
Secondary measures include sexual function, pain quality, psychological factors (including pain catastrophizing, anxiety, depression and fear of pain), PFM morphology and function, and patients' global impression of change.
